谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

P006: Long-term Safety and Efficacy of Pegunigalsidase Alfa Administered Every 4 Weeks in Fabry Disease: 2-Year Interim Results from BRIGHT51

John Bernat,Myrl Holida,Nicola Longo,Ozlem Goker-Alpan,Eric Wallace,Patrick Deegan,Camilla Tondel,Francois Eyskens,Ulla Feldt-Rasmussen,Derralynn Hughes,Antonio Pisani,Ales Linhart,Rossana Rocco,Einat Almon,Sari Alon,Raul Chertkoff,David Warnock,Stephen Waldek,William Wilcox

Genetics in Medicine Open（2023）

引用 0|浏览2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要